Glucocorticoid-Induced Osteoporosis

Guidelines

2022 GIOP Guideline

2022 Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (GIOP) Summary - Updated November 9, 2022

Update to 2017 ACR Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (final publication anticipated early 2023).

2017 GIOP Guideline

2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Documents related to this guideline:

• Appendix 1 – Methods
• Appendix 2 – Panel/Teams Involved
• Appendix 3 – Evidence Report
• Appendix 4 – Search Strategies
• Appendix 5 – Study Selection Process
• Disclosure Summary of ACR Committee Reviewers
• Project Plan
• Public Comments
• Author Response to Public Comments

2010 GIOP Guideline

American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Clinician’s Guide to the American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Endorsed by the American Society for Bone and Mineral Research.